These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21235349)

  • 1. Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function.
    Tocchetti CG; Stanley BA; Murray CI; Sivakumaran V; Donzelli S; Mancardi D; Pagliaro P; Gao WD; van Eyk J; Kass DA; Wink DA; Paolocci N
    Antioxid Redox Signal; 2011 May; 14(9):1687-98. PubMed ID: 21235349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.
    Kemp-Harper BK; Velagic A; Paolocci N; Horowitz JD; Ritchie RH
    Handb Exp Pharmacol; 2021; 264():311-337. PubMed ID: 32813078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric Oxide Resistance, Induced in the Myocardium by Diabetes, Is Circumvented by the Nitric Oxide Redox Sibling, Nitroxyl.
    Qin CX; Anthonisz J; Leo CH; Kahlberg N; Velagic A; Li M; Jap E; Woodman OL; Parry LJ; Horowitz JD; Kemp-Harper BK; Ritchie RH
    Antioxid Redox Signal; 2020 Jan; 32(1):60-77. PubMed ID: 31680536
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitroxyl (HNO): a novel redox signaling molecule.
    Kemp-Harper BK
    Antioxid Redox Signal; 2011 May; 14(9):1609-13. PubMed ID: 21299468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of nitroxyl (HNO) as a pharmacological agent.
    Switzer CH; Flores-Santana W; Mancardi D; Donzelli S; Basudhar D; Ridnour LA; Miranda KM; Fukuto JM; Paolocci N; Wink DA
    Biochim Biophys Acta; 2009 Jul; 1787(7):835-40. PubMed ID: 19426703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
    Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
    Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updating NO
    Suarez SA; Vargas P; Doctorovich FA
    J Inorg Biochem; 2021 Mar; 216():111333. PubMed ID: 33385637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroxyl (HNO): the Cinderella of the nitric oxide story.
    Irvine JC; Ritchie RH; Favaloro JL; Andrews KL; Widdop RE; Kemp-Harper BK
    Trends Pharmacol Sci; 2008 Dec; 29(12):601-8. PubMed ID: 18835046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.
    Flores-Santana W; Salmon DJ; Donzelli S; Switzer CH; Basudhar D; Ridnour L; Cheng R; Glynn SA; Paolocci N; Fukuto JM; Miranda KM; Wink DA
    Antioxid Redox Signal; 2011 May; 14(9):1659-74. PubMed ID: 21235346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroxyl (HNO) targets phospholamban cysteines 41 and 46 to enhance cardiac function.
    Keceli G; Majumdar A; Thorpe CN; Jun S; Tocchetti CG; Lee DI; Mahaney JE; Paolocci N; Toscano JP
    J Gen Physiol; 2019 Jun; 151(6):758-770. PubMed ID: 30842219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.
    Kemp-Harper BK; Horowitz JD; Ritchie RH
    Drugs; 2016 Sep; 76(14):1337-48. PubMed ID: 27566478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitroxyl (HNO) reacts with molecular oxygen and forms peroxynitrite at physiological pH. Biological Implications.
    Smulik R; Dębski D; Zielonka J; Michałowski B; Adamus J; Marcinek A; Kalyanaraman B; Sikora A
    J Biol Chem; 2014 Dec; 289(51):35570-81. PubMed ID: 25378389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative heme protein-mediated nitroxyl (HNO) generation.
    Reisz JA; Bechtold E; King SB
    Dalton Trans; 2010 Jun; 39(22):5203-12. PubMed ID: 20502824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function.
    Gao WD; Murray CI; Tian Y; Zhong X; DuMond JF; Shen X; Stanley BA; Foster DB; Wink DA; King SB; Van Eyk JE; Paolocci N
    Circ Res; 2012 Sep; 111(8):1002-11. PubMed ID: 22851540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm.
    Wink DA; Miranda KM; Katori T; Mancardi D; Thomas DD; Ridnour L; Espey MG; Feelisch M; Colton CA; Fukuto JM; Pagliaro P; Kass DA; Paolocci N
    Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2264-76. PubMed ID: 12855429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties.
    Shoman ME; Aly OM
    Oxid Med Cell Longev; 2016; 2016():4867124. PubMed ID: 26770654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins. A chemical discussion of the differential biological effects of these redox related products of NOS.
    Miranda KM; Nims RW; Thomas DD; Espey MG; Citrin D; Bartberger MD; Paolocci N; Fukuto JM; Feelisch M; Wink DA
    J Inorg Biochem; 2003 Jan; 93(1-2):52-60. PubMed ID: 12538052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling.
    Paolocci N; Katori T; Champion HC; St John ME; Miranda KM; Fukuto JM; Wink DA; Kass DA
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5537-42. PubMed ID: 12704230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in research on treatment of heart failure with nitrosyl hydrogen.
    Guo Y; Xu J; Wu L; Deng Y; Wang J; An J
    Heart Fail Rev; 2019 Nov; 24(6):941-948. PubMed ID: 31069588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HNO donor Angeli's salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia-reperfusion injury in the rat heart ex vivo.
    Chin KY; Michel L; Qin CX; Cao N; Woodman OL; Ritchie RH
    Pharmacol Res; 2016 Feb; 104():165-75. PubMed ID: 26747404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.